ID: ALA436986

Max Phase: Preclinical

Molecular Formula: C39H72N12O11

Molecular Weight: 885.08

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C39H72N12O11/c1-20(2)15-26(47-30(52)19-45-32(55)23(7)46-33(56)24(41)11-10-14-44-39(42)43)34(57)49-28(17-22(5)6)36(59)51-29(18-31(53)54)37(60)50-27(16-21(3)4)35(58)48-25(38(61)62)12-8-9-13-40/h20-29H,8-19,40-41H2,1-7H3,(H,45,55)(H,46,56)(H,47,52)(H,48,58)(H,49,57)(H,50,60)(H,51,59)(H,53,54)(H,61,62)(H4,42,43,44)/t23-,24-,25-,26-,27-,28-,29-/m0/s1

Standard InChI Key:  KQOKLCQFPKMKRW-BMGWUDNWSA-N

Associated Targets(non-human)

Hypothalamus (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 885.08Molecular Weight (Monoisotopic): 884.5444AlogP: -2.55#Rotatable Bonds: 31
Polar Surface Area: 392.24Molecular Species: ZWITTERIONHBA: 12HBD: 14
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.72CX Basic pKa: 11.54CX LogP: -6.78CX LogD: -7.25
Aromatic Rings: 0Heavy Atoms: 62QED Weighted: 0.02Np Likeness Score: 0.23

References

1. Rego JL, Leprince J, Luu-The V, Pelletier G, Tonon MC, Vaudry H..  (2007)  Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.,  50  (13): [PMID:17550241] [10.1021/jm0610548]

Source